Please login to the form below

Not currently logged in
Email:
Password:

Flu vaccine subsidy for Takeda

Takeda Pharmaceutical is to receive a 23.9bn Yen subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines

Takeda Pharmaceutical is to receive a 23.9bn Yen (€215m) subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines.

The company's current influenza-related projects include an agreement with Baxter International to develop the proprietary Vero cell culture-based influenza vaccine technology.

Takeda has already introduced the technology into its experimental production facilities Hikari City having received a similar subsidy in 2010.

The extra funding will enable Takeda to continue the development work it had commenced and make preparations for full-scale manufacturing, including constructing a commercial production facility at the Hikari plant.

A new drug approval for an influenza vaccine is expected by the end of the financial year 2013, according to Takeda.

23rd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....

Infographics